Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 116.42%. However, over the past six months, we’ve seen a stronger performance of -0.68%. The price of TRVI leaped by -3.01% over the last 30 days. And in the last five days, it has fallen by -1.53%.
In terms of market performance, Trevi Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $4.00 on 03/21/24, and the lowest value was recorded at $0.97 on 11/27/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of TRVI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Trevi Therapeutics Inc’s current trading price is -27.50% away from its 52-week high, while its distance from the 52-week low is 198.97%. The stock’s price range during this period has varied between$0.97 and $4.00. The Trevi Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.76 million for the day, a figure considerably higher than their average daily volume of 0.35 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Trevi Therapeutics Inc (TRVI) has experienced a quarterly rise of 1.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 210.51M and boasts a workforce of 25 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.99, with a change in price of +0.20. Similarly, Trevi Therapeutics Inc recorded 328,092 in trading volume during the last 100 days, posting a change of +7.21%.
TRVI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TRVI stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
TRVI Stock Stochastic Average
Trevi Therapeutics Inc’s raw stochastic average for the past 50 days is presently 14.13%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 15.63%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.20% and 30.98%, respectively.
